Unité d'Évaluation des Technologies et des Modes d'Intervention en Santé and Centre de Recherche du Centre hospitalier universitaire de Sherbrooke, Centre Intégré Universitaire de Santé et Services Sociaux de l'Estrie-CHUS, Sherbrooke, QC, Canada.
Department of Economics, University of Sherbrooke, Sherbrooke, QC, Canada.
Value Health. 2019 Jul;22(7):837-842. doi: 10.1016/j.jval.2018.12.012. Epub 2019 May 17.
BACKGROUND: The Short Form 6 Dimension (SF-6D) is a multi-attribute utility instrument derived from the Short-Form 36 Health Survey Version 2 (SF-36v2) quality of life questionnaire and is used to calculate quality-adjusted life years (QALYs) on a scale 0 to 1. The SF-6Dv2 is a new version of the SF-6D. OBJECTIVE: The aim of this study was to assess the consistency of respondents' answers to 3 different methods to administer this new version. METHODS: SF-6Dv2 utility values were generated from the SF-36v2 using the following: (1) full questionnaire with 36 items (SF-6Dv2); (2) subset questionnaire with 10 items (SF-6Dv2); (3) SF-6Dv2 administered as an independent instrument (rephrased questionnaire with only 6 items [SF-6Dv2]). The order of the 3 instruments was randomly allocated between respondents. RESULTS: A total of 782 respondents from Quebec, Canada, were interviewed, out of whom 697 fully completed the survey. Very few deviations in respondents' answers were observed between the 3 instruments, with mean weighted kappa of 0.79 (range 0.61-0.91) and mean global consistency index of 70% (range 54-83). Maximal difference in utility values generated was found between SF-6Dv2 and SF-6Dv2 (mean difference 0.016, P < .01), whereas minimal difference was found between SF-6Dv2 and SF-6Dv2 (0.002, P = .38). No ceiling effect was observed. CONCLUSIONS: The SF-6Dv2 was designed to derive utilities from the SF-36v2, and our results indicate that it is still preferable to use the full questionnaire, although the difference with other variants of the questionnaire is very small. To use the SF-6Dv2 as an independent instrument will thus introduce minimal bias in utility values generated.
背景:简短表格 6 维度(SF-6D)是一种源自简短表格 36 健康调查版本 2(SF-36v2)的多维效用工具,用于在 0 到 1 的范围内计算质量调整生命年(QALYs)。SF-6Dv2 是 SF-6D 的新版本。
目的:本研究旨在评估受访者对 3 种不同管理新版本方法的答案的一致性。
方法:使用以下方法从 SF-36v2 生成 SF-6Dv2 效用值:(1)包含 36 个项目的完整问卷(SF-6Dv2);(2)包含 10 个项目的子问卷(SF-6Dv2);(3)作为独立工具管理的 SF-6Dv2(重新表述的只有 6 个项目的问卷[SF-6Dv2])。受访者之间随机分配 3 种仪器的顺序。
结果:从加拿大魁北克省共采访了 782 名受访者,其中 697 名受访者完整完成了调查。在 3 种仪器之间,受访者的答案几乎没有偏差,加权平均 kapp 值为 0.79(范围为 0.61-0.91),平均总体一致性指数为 70%(范围为 54-83)。在效用值生成中发现 SF-6Dv2 和 SF-6Dv2 之间的最大差异(平均差异 0.016,P<.01),而 SF-6Dv2 和 SF-6Dv2 之间的最小差异(0.002,P=.38)。未观察到上限效应。
结论:SF-6Dv2 旨在从 SF-36v2 中推导出效用,我们的结果表明,尽管与问卷的其他变体差异很小,但最好还是使用完整的问卷。因此,使用 SF-6Dv2 作为独立工具将在生成的效用值中引入最小的偏差。
Expert Rev Pharmacoecon Outcomes Res. 2021-10
Value Health. 2013
Breast Cancer. 2021-7
Breast Cancer. 2021-1
Pharmacoeconomics. 2021-8
Health Qual Life Outcomes. 2025-1-12
Appl Health Econ Health Policy. 2025-3
Appl Health Econ Health Policy. 2025-1
Health Qual Life Outcomes. 2024-4-19
Int J Environ Res Public Health. 2022-7-13
Health Qual Life Outcomes. 2022-6-20
Health Qual Life Outcomes. 2022-6-16